SmartPharm is a second-generation, gene-encoded therapeutics company with a goal of replacing conventional biologics therapy with proteins produced by the patient: biologics from within. We are implementing non-viral nucleic acid technology platforms with superior expression performance. We draw from multiple novel nucleic acid technologies to generate gene-based biologics optimized for the intended therapeutic effect in the patients, and leverage an integrated, international development network in support of an aggressive pace of therapeutic development. SmartPharm’s initial therapeutic areas of interest include cardiology, oncology and autoimmune diseases.
- Jose Trevejo, MD, PhD Co-Founder
- Timothy Brauns, MBA Co-Founder & Chief Operating Officer
- John Thomas, CPA Chief Financial Officer